BSX’s Alair Receives Reimbursement – Zacks.com

BSX's Alair Receives Reimbursement
Zacks.com
Data from the Research in Severe Asthma (“RISA”) trial found that patients with severe refractory asthma, when treated with Alair BT system, experienced stability in lung function without clinical complications over a five-year period.
St. Luke's Episcopal Hospital Offers Bronchial Thermoplasty Treating Severe MarketWatch (press release)
CMS acknowledges clinical improvement linked with use of Alair Bronchial News-Medical.net
Boston Scientific's Alair thermoplasty system wins CMS approvalZenopa

all 10 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.